Tag: heart failure

New Australian research and development partnership aims to innovate heart failure...

Biotronik, the University of Newcastle (in Australia), and the John Hunter New England Local Health District have partnered to shape a future heart failure...

First trial of in-heart micro device for left atrial pressure monitoring...

Vectorious Medical Technologies has announced the initiation of the VECTOR-HF first-in-human (FIH) clinical trial, and the successful first “in-human” implantation of the V-LAPTM monitoring...

EACTS 2018: From bench to bedside: Roundtrip for cell therapy in...

The study of stem cells in regenerative medicine is a growing field of basic and clinical research, generating a broad interest and debate in...

HeartWare HVAD system receives US FDA approval

Medtronic has received United States Food and Drug Administration (FDA) approval for a less-invasive implant approach of its HVAD System, a left ventricular assist...

Nearly 25% of chronic ischaemic heart disease patients dead or hospitalised...

    Nearly a quarter of patients with chronic ischaemic cardiovascular disease are dead or hospitalised within six months, reports a European Society of Cardiology (ESC) study...

Abbott’s Full MagLev HeartMate 3 LVAD receives FDA approval

The FDA has approved the Full MagLev HeartMate 3 (Abbott) left ventricular assist device for use in heart failure patients in need of short-term...
Woman patient

Heart failure patient and clinician risk perceptions differ drastically

Physicians identified a majority of patients with advanced heart failure as at high risk for transplant, left ventricular assist device (LVAD) or death while...

EuroPCR 2017: Interventional management of acute heart failure—which device, when and...

In this PCR video, filmed during EuroPCR (16–19 May, Paris, France), Atul Pathak (Clinique Pasteur, Toulouse, France) speaks to Daniel Burkhoff (Division of Cardiology, Columbia...

Halting methamphetamine abuse can reverse related heart damage

Quitting methamphetamine use can reverse the damage the drug causes to the heart and improve heart function in abusers when combined with appropriate medical...

Non-O blood groups associated with higher risk of heart attack

Having a non-O blood group is associated with a higher risk of heart attack, according to research presented at Heart Failure 2017 and the...

ACC 2017: More hospitalisations & deaths for US heart failure patients...

Patients with heart failure in the USA are more likely to be hospitalised and more likely to die during the colder winter months, according...

First patient treated with CardiAmp cell therapy for ischaemic heart failure...

Johns Hopkins Medicine, Baltimore, USA, the Maryland Stem Cell Research Fund (MSCRF) and BioCardia have announced that the first patient has been treated in...

Increased physical activity, lower BMI may lower heart failure risk

While lifestyle patterns, including physical activity and body mass index (BMI), are associated with overall heart failure risk, they are more strongly associated with...

Cancer drug promotes regeneration of damaged heart tissue

An anticancer agent in development has been shown to promote regeneration of damaged heart muscle—an unexpected research finding that may help prevent congestive heart...

Northwestern Memorial Hospital ranked best in USA for heart attack, stroke...

Northwestern Memorial Hospital has been ranked best in the USA for survival of patients suffering heart failure, and second for survival of patients with...

Latest statistics show heart failure on the rise

The number of adults living with heart failure increased from about 5.7 million (2009-2012) to about 6.5 million (2011-2014), according to the American Heart...

AHA 2016: Elizabeth M McNally wins AHA prize for research into...

The American Heart Association (AHA) awarded its Basic Research Prize for 2016 to Elizabeth M McNally (Chicago, USA) for “Ground-breaking investigations of novel genetic...

Japan approves Abiomed’s Impella 2.5 and Impella 5.0 heart pumps

Abiomed has announced that its heart pumps Impella 2.5 and Impella 5.0 have received Pharmaceuticals and Medical Devices Agency (PMDA) approval from the Japanese...

Berlin Heals announces closure of second round funding for cardiac microcurrent...

Berlin Heals has closed a second investment round in the run-up to the first-in-man application of its implantable medical device for the treatment of...